SL 0101-1 T16896
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
SL 0101-1 is a cell-permeable, selective, reversible, ATP-competitive p90 Ribosomal S6 Kinase inhibitor (IC50: 89 nM). It shows proliferation inhibition in human breast cancer cell line MCF-7 and produces a cell cycle block in G1 phase.
CAS nr:
77307-50-7
Purity:
98%
Molecular Weight:
516,45
SMILES:
OC1=CC(O)=C(C(C(O[C@@H]2O[C@@H](C)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@H]2O)=C(C3=CC=C(O)C=C3)O4)=O)C4=C1
Formula:
C25H24O12
Pathway:
Others
Target:
Others
